ETCM
PRCT icon

Evolutionary Tree Capital Management’s Procept Biorobotics PRCT Stock Holding History

Evolutionary Tree Capital Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09M Sell
48,101
-18,768
-28% -$470K 2.05% 25
2026
Q1 		$1.67M Sell
66,869
-34,041
-34% -$959K 3.14% 16
2025
Q4 		$3.17M Buy
100,910
+25,893
+35% +$859K 3.69% 10
2025
Q3 		$2.68M Sell
75,017
-14
-0% -$639 2.92% 17
2025
Q2 		$4.32M Buy
75,031
+1,164
+2% +$65.8K 4.59% 7
2025
Q1 		$4.3M Buy
73,867
+12,749
+21% +$870K 5% 5
2024
Q4 		$4.92M Sell
61,118
-8,725
-12% -$745K 5.01% 5
2024
Q3 		$5.6M Buy
69,843
+3,604
+5% +$256K 5.6% 5
2024
Q2 		$4.05M Buy
66,239
+16,352
+33% +$973K 4.16% 6
2024
Q1 		$2.47M Buy
49,887
+781
+2% +$37.2K 2.48% 15
2023
Q4 		$2.06M Buy
49,106
+46
+0.1% +$1.57K 2.27% 16
2023
Q3 		$1.61M Buy
49,060
+7,712
+19% +$263K 2.08% 18
2023
Q2 		$1.46M Buy
41,348
+6,953
+20% +$230K 1.76% 23
2023
Q1 		$977K Buy
+34,395
New +$1.21M 1.35% 26

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Evolutionary Tree Capital Management's PRCT Position: Q2 2026 in Review

Evolutionary Tree Capital Management reduced its Procept Biorobotics (PRCT) stake by 28% in Q2 2026, selling an estimated $470K and leaving 48,101 shares worth $1.09M. The position accounts for 2.05% of the portfolio, ranked #25.

Evolutionary Tree Capital Management first reported a position in PRCT in Q1 2023 and has held it in 14 quarters since. The position peaked at $5.6M in Q3 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Evolutionary Tree Capital Management held 48,101 shares of Procept Biorobotics worth $1.09M as of Q2 2026.
  • Evolutionary Tree Capital Management sold 18,768 Procept Biorobotics shares in Q2 2026, an estimated $470K.
  • Procept Biorobotics made up 2.05% of Evolutionary Tree Capital Management's portfolio in Q2 2026, its #25 holding.
  • Evolutionary Tree Capital Management first reported a position in Procept Biorobotics in Q1 2023 and has held it in 14 quarters since.
  • Evolutionary Tree Capital Management's Procept Biorobotics position peaked at $5.6M in Q3 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Evolutionary Tree Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.